These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 4800160)

  • 1. Catalepsy, sedation and hypothermia induced by alpha-methyl-p-tyrosine in the rat. An ideal tool for screening of drugs active on central catecholaminergic receptors.
    Papeschi R; Randrup A
    Pharmakopsychiatr Neuropsychopharmakol; 1973 May; 6(3):137-57. PubMed ID: 4800160
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacological effects of 1,3-dimethyl-5-aminoadamantane, a new adamantane derivative.
    Maj J; Sowińska H; Baran L; Sarnek J
    Eur J Pharmacol; 1974 Apr; 26(1):9-14. PubMed ID: 4857604
    [No Abstract]   [Full Text] [Related]  

  • 3. Antagonism by alpha-methyltyrosine of morphine induced motility in non-tolerant and tolerant rats.
    Davis WM; Babbini M; Khalsa HJ
    Res Commun Chem Pathol Pharmacol; 1972 Sep; 4(2):267-79. PubMed ID: 5074526
    [No Abstract]   [Full Text] [Related]  

  • 4. [Significance of catecholamines for the manifestation of morphine withdrawal in the rat].
    Bläsig J; Papeschi R; Herz A
    Arzneimittelforschung; 1974 Jul; 24(7):1015-6. PubMed ID: 4408108
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of anti-Parkinson drugs on catalepsy induced by -methyl-p-tyrosine in rats pretreated with intraventricular 6-hydroxydopamine.
    Cashin CH; Sutton S
    Br J Pharmacol; 1973 Mar; 47(3):658P-659P. PubMed ID: 4738385
    [No Abstract]   [Full Text] [Related]  

  • 6. Enhanced sensitivity to noradrenergic agonists and tolerance development to -methyltyrosine in the rat.
    Beuthin FC; Miya TS; Blake DE; Bousquet WF
    J Pharmacol Exp Ther; 1972 Jun; 181(3):446-56. PubMed ID: 5033011
    [No Abstract]   [Full Text] [Related]  

  • 7. Central action of drugs acting on the cholinergic muscarinic receptor. III. Influence of atropine and scopolamine injected intraventricularly on behavior and levels of biogenic amines in the rat brain.
    Zebrowska-Lupina I; Kleinrok Z; Poddubiuk Z
    Arch Immunol Ther Exp (Warsz); 1975; 23(4):485-95. PubMed ID: 1172421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of catecholaminergic mechanisms in the expression of the morphine abstinence syndrome in rats.
    Herz A; Bläsig J; Papeschi R
    Psychopharmacologia; 1974; 39(2):121-43. PubMed ID: 4476079
    [No Abstract]   [Full Text] [Related]  

  • 9. Significance of dopamine receptor activity in dl-p-methoxyamphetamine- and d-amphetamine-induced locomotor activity.
    Tseng LF; Loh HH
    J Pharmacol Exp Ther; 1974 Jun; 189(3):717-24. PubMed ID: 4858403
    [No Abstract]   [Full Text] [Related]  

  • 10. Solcoseryl stimulates behavioural activity of rats.
    Braszko JJ; Winnicka MM; Wiśniewski K
    Acta Physiol Hung; 1996; 84(1):63-72. PubMed ID: 8993676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of dopamine in pilocarpine-induced catalepsy.
    Ahtee L; Kääriäinen I
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 284(1):25-38. PubMed ID: 4279348
    [No Abstract]   [Full Text] [Related]  

  • 12. Some actions of pentazocine on behavior and brain monoamines in the rat.
    Holtzman SG; Jewett RE
    J Pharmacol Exp Ther; 1972 May; 181(2):346-56. PubMed ID: 5030675
    [No Abstract]   [Full Text] [Related]  

  • 13. A comparison of the locomotor stimulant properties of amantadine and l- and d-amphetamine in mice.
    Thornburg JE; Moore KE
    Neuropharmacology; 1972 Sep; 11(5):675-82. PubMed ID: 4151250
    [No Abstract]   [Full Text] [Related]  

  • 14. Analysis of the aggressiveness-stereotypy complex induced in mice by amphetamine or D,L-dopa. II.
    Roliński Z
    Pol J Pharmacol Pharm; 1974; 26(3):369-78. PubMed ID: 4277363
    [No Abstract]   [Full Text] [Related]  

  • 15. Preliminary pharmacological evaluation of chelidonine in rodents.
    Jagiełło-Wójtowicz E; Jusiak L; Szponar J; Kleinrok Z
    Pol J Pharmacol Pharm; 1989; 41(2):125-31. PubMed ID: 2594578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amantadine may stimulate dopamine and noradrenaline receptors.
    Papeschi R
    Neuropharmacology; 1974 Jan; 13(1):77-83. PubMed ID: 4522901
    [No Abstract]   [Full Text] [Related]  

  • 17. Modification by disulfiram or methyltyrosine methylester (H 44-68) of abstinence symptoms in morphine-tolerant rats.
    Mattila MJ; Alhava E; Mansner R
    Arzneimittelforschung; 1968 Sep; 18(9):1163-6. PubMed ID: 5755932
    [No Abstract]   [Full Text] [Related]  

  • 18. Behavioral effects of alpha-methyltyrosine after prior depletion of brain catecholamines.
    Rech RH; Carr LA; Moore KE
    J Pharmacol Exp Ther; 1968 Apr; 160(2):326-35. PubMed ID: 5651375
    [No Abstract]   [Full Text] [Related]  

  • 19. Central action of sanumgerman in mice.
    Kleinrok Z; Lekim D; Jagiełło-Wójtowicz E; Chodkowska A
    Pol J Pharmacol Pharm; 1986; 38(3):299-307. PubMed ID: 3774627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proceedings: CB 154 (2-bromo-alpha-ergokryptine, bromocriptin), a potential anti-Parkinson agent.
    Johnson AM; Vigouret JM; Loew DM
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R40. PubMed ID: 4276573
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.